Nascent Biotech Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

NBIO

organization

SIC: 2834

SEC Insider

$11.3M

128 transactions

Summary

Nascent Biotech Inc. (NBIO) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $3.3MSales: $1K5 insiders

Date	Insider	Type	Value
2023-09-29	Carrick Sean(President & CEO)	J	$360K
2023-09-29	HOLDEN LOWELL THOMAS(CFO)	J	$180K
2023-02-09	HOLDEN LOWELL THOMAS(CFO)	G	$84K
2023-03-31	Carrick Sean(President & CEO)	J	$70K
2023-06-29	Carrick Sean(President & CEO)	G	$48K
2023-12-29	Carrick Sean(President & CEO)	J	$41K
2024-03-31	Carrick Sean(President & CEO)	J	$41K
2023-06-29	HOLDEN LOWELL THOMAS(CFO)	G	$35K
2023-03-31	HOLDEN LOWELL THOMAS(CFO)	J	$35K
2023-12-29	HOLDEN LOWELL THOMAS(CFO)	J	$20K
2024-03-31	HOLDEN LOWELL THOMAS(CFO)	J	$20K
2024-06-30	Carrick Sean(President & CEO)	J	$17K
2024-06-30	HOLDEN LOWELL THOMAS(CFO)	J	$9K
2023-03-31	Karas Douglas John	J	$5K
2023-12-29	Karas Douglas John	J	$5K
2023-06-07	HOLDEN LOWELL THOMAS(CFO)	Buy	$5K
2023-09-29	Karas Douglas John	J	$5K
2024-06-30	Karas Douglas John	J	$5K
2024-03-31	Karas Douglas John	J	$5K
2023-01-27	HOLDEN LOWELL THOMAS(CFO)	Buy	$3K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Nascent Biotech Inc. — Contributions, Lobbying & Contracts | Poliscope